KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $108.0 million.

  • Bristol Myers Squibb's Other Non Operating Income rose 14615.38% to $108.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 37465.44%. This contributed to the annual value of -$893.0 million for FY2024, which is 17711.57% down from last year.
  • Bristol Myers Squibb's Other Non Operating Income amounted to $108.0 million in Q3 2025, which was up 14615.38% from -$494.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Other Non Operating Income's 5-year high stood at $702.0 million during Q1 2021, with a 5-year trough of -$649.0 million in Q1 2022.
  • For the 5-year period, Bristol Myers Squibb's Other Non Operating Income averaged around -$16.6 million, with its median value being $2.0 million (2021).
  • Per our database at Business Quant, Bristol Myers Squibb's Other Non Operating Income plummeted by 1430000.0% in 2022 and then surged by 16363.64% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Other Non Operating Income (Quarter) stood at -$393.0 million in 2021, then skyrocketed by 155.22% to $217.0 million in 2022, then skyrocketed by 70.97% to $371.0 million in 2023, then crashed by 182.21% to -$305.0 million in 2024, then soared by 135.41% to $108.0 million in 2025.
  • Its Other Non Operating Income was $108.0 million in Q3 2025, compared to -$494.0 million in Q2 2025 and -$339.0 million in Q1 2025.